Literature DB >> 3244380

The measurement of norepinephrine clearance and spillover rate into plasma in conscious spontaneously hypertensive rats.

T K Keeton1, A M Biediger.   

Abstract

The clearance of norepinephrine from plasma and the spillover rate of norepinephrine into plasma were determined in conscious unrestrained spontaneously hypertensive rats by measuring the concentrations of 3H-norepinephrine and norepinephrine in arterial plasma after 90 min of i.v. infusion with 3H-norepinephrine. In 50 conscious spontaneously hypertensive rats treated with saline (control animals), the following basal values were obtained: plasma norepinephrine concentration = 149 +/- 5 pg/ml; plasma epinephrine concentration = 61 +/- 4 pg/ml; norepinephrine clearance = 188 +/- 4 ml min-1 kg-1; and norepinephrine spillover rate = 27.5 +/- 0.8 ng min-1 kg-1. A significant portion of infused 3H-norepinephrine appeared to be cleared from the plasma by the uptake1 process, since desipramine decreased norepinephrine clearance by 32%. The vasodilating agents hydralazine and minoxidil produced dose-related increases in norepinephrine spillover rate and plasma norepinephrine concentration, but the percent increases in norepinephrine spillover rate exceeded the percent increases in plasma norepinephrine concentration because of concomitant increases in norepinephrine clearance, particularly after treatment with minoxidil. The increase in norepinephrine clearance caused by hydralazine and minoxidil probably resulted from the increase in cardiac output and resultant increase in hepatic and/or pulmonary blood flow. Adrenal secretion of norepinephrine did not appear to contribute to the elevation in norepinephrine spillover rate elicited by hydralazine and minoxidil. Chlorisondamine suppressed norepinephrine spillover rate by 77%, in association with a 70% decline in plasma epinephrine concentration, whereas bretylium lowered norepinephrine spillover rate by only 41%, with no change in plasma epinephrine concentration. The decrements in norepinephrine clearance caused by chlorisondamine (-23%) and bretylium (-15%) were more or less proportional to the magnitude of the vasodepression caused by these drugs. Both norepinephrine spillover rate and clearance fell in a dose-related fashion after treatment with clonidine. After treatment with the sympathoinhibitory agents chlorisondamine, bretylium and clonidine, the percent decreases in norepinephrine spillover rate always exceeded the percent decreases in plasma norepinephrine concentration. Based on these observations, we conclude that norepinephrine spillover rate provides a more accurate measurement of the activity of the peripheral sympathetic nervous system than does plasma norepinephrine concentration in conscious spontaneously hypertensive rats.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3244380     DOI: 10.1007/bf00172109

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  51 in total

1.  Preferential metabolism of (-) 3 H-norepinephrine through the deaminated glycol in the rat vas deferens.

Authors:  K H Graffe; F J Stefano; S Z Langer
Journal:  Biochem Pharmacol       Date:  1973-05-15       Impact factor: 5.858

2.  Systemic and coronary hemodynamic effects of pinacidil, a new antihypertensive agent, in awake dogs: comparison with hydralazine.

Authors:  S Kawashima; C S Liang
Journal:  J Pharmacol Exp Ther       Date:  1985-02       Impact factor: 4.030

Review 3.  Assessment of sympathetic nervous function in humans from noradrenaline plasma kinetics.

Authors:  M Esler
Journal:  Clin Sci (Lond)       Date:  1982-03       Impact factor: 6.124

4.  Changes in plasma noradrenaline concentration as a measure of release rate.

Authors:  C R Benedict; M Fillenz; C Stanford
Journal:  Br J Pharmacol       Date:  1978-10       Impact factor: 8.739

5.  Comparison of hemodynamics in conscious spontaneous and renal hypertensive rats.

Authors:  R A Ferrone; G M Walsh; M Tsuchiya; E D Frohlich
Journal:  Am J Physiol       Date:  1979-03

6.  Pulmonary extraction of circulating noradrenaline in man.

Authors:  J H Henriksen; N J Christensen; H Ring-Larsen
Journal:  Eur J Clin Invest       Date:  1986-10       Impact factor: 4.686

7.  Actions of bretylium and guanethidine on the uptake and release of [3H]-noradrenaline.

Authors:  G HERTTING; J AXELROD; R W PATRICK
Journal:  Br J Pharmacol Chemother       Date:  1962-02

8.  Plasma l-[3H]norepinephrine, d-[14C]norepinephrine, and d,l-[3H]isoproterenol kinetics in essential hypertension.

Authors:  D S Goldstein; D Horwitz; H R Keiser; R J Polinsky; I J Kopin
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

9.  The noradrenaline rate in the anaesthetized rabbit: facilitation by adrenaline.

Authors:  H Majewski; L Hedler; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-10       Impact factor: 3.000

10.  Response of plasma norepinephrine concentration to the vasodepression caused by beta-adrenoceptor antagonists in the conscious spontaneously hypertensive rat.

Authors:  T K Keeton; J S Hall; A M Biediger
Journal:  J Cardiovasc Pharmacol       Date:  1987-03       Impact factor: 3.105

View more
  10 in total

1.  Cyclooxygenase-1 inhibition attenuates angiotensin II-salt hypertension and neurogenic pressor activity in the rat.

Authors:  Ninitha Asirvatham-Jeyaraj; Andrew J King; Carrie A Northcott; Shivanshu Madan; Gregory D Fink
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-09-06       Impact factor: 4.733

Review 2.  In vivo assessment of neurocardiovascular regulation in the mouse: principles, progress, and prospects.

Authors:  Colin N Young; Robin L Davisson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-24       Impact factor: 4.733

3.  Propranolol and atenolol inhibit norepinephrine spillover rate into plasma in conscious spontaneously hypertensive rats.

Authors:  T K Keeton; A M Biediger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-07       Impact factor: 3.000

4.  Mild DOCA-salt hypertension: sympathetic system and role of renal nerves.

Authors:  Sachin S Kandlikar; Gregory D Fink
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-25       Impact factor: 4.733

5.  Desipramine inhibits sympathetic nerve activity in the rabbit.

Authors:  B Sazbo; A Schultheiss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-10       Impact factor: 3.000

Review 6.  Sympathetic nerve function--assessment by radioisotope dilution analysis.

Authors:  Graeme Eisenhofer
Journal:  Clin Auton Res       Date:  2005-08       Impact factor: 4.435

7.  Splanchnic sympathetic nerves in the development of mild DOCA-salt hypertension.

Authors:  Sachin S Kandlikar; Gregory D Fink
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-02       Impact factor: 4.733

8.  Simultaneous determination of plasma noradrenaline and adrenaline kinetics. Responses to nitroprusside-induced hypotension and 2-deoxyglucose-induced glucopenia in the rabbit.

Authors:  O S Medvedev; M D Esler; J A Angus; H S Cox; G Eisenhofer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

9.  Total body, systemic and pulmonary clearance and fractional extraction of unlabelled and differently 3H-labelled noradrenaline in the anaesthetized rabbit.

Authors:  T Halbrügge; A L Ungell; R Wölfel; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

10.  Inhibition of uptake 1 by (+)-oxaprotiline reveals a differential central regulation of noradrenaline and adrenaline release.

Authors:  B Szabo; T Auberle; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-09       Impact factor: 3.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.